G Riou

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

Ute M. Moll, G Riou, Arnold J. Levine · Proceedings of the National Academy of Sciences · 1992 · 580 citations · Full text

Distinct Mechanisms, Breast Oncology, Pathology +16

Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.

Ute M. Moll, Michael P. LaQuaglia, Jean Bénard et al. · Proceedings of the National Academy of Sciences · 1995 · 428 citations · Full text

Tumoral Pathology, Glioma, Malignant Disease +13

Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice.

Jean Bénard, J Da Silva, Mathilde Blois et al. · PubMed · 1985 · 293 citations

Gynecology, Pathology, Cell Proliferation +17

High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.

J.C. Ahomadegbe, Michel Barrois, Sandy Fogel et al. · PubMed · 1995 · 198 citations

Structure and expression of c‐<i>erb</i>B‐2 and EGF receptor genes in inflammatory and non‐inflammatory breast cancer: Prognostic significance

Martine Guérin, M Gabillot, Marie‐Christine Mathieu et al. · International Journal of Cancer · 1989 · 193 citations